NDADENTALPOWDER, EXTENDED RELEASE
Approved
Feb 2001
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
5/8 — Partial
ARESTIN (minocycline hydrochloride) by Fosun Pharma is mechanism of action the mechanism of action of arestin as an adjunct to scaling and root planing procedures for reduction of pocket depth in patients with adult periodontitis is unknown. First approved in 2001.
Drug data last refreshed 18h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ARESTIN is a minocycline hydrochloride extended-release powder administered locally via dental injection as an adjunct to scaling and root planing for adult periodontitis. The precise mechanism of action remains unknown, but the product is positioned to reduce pocket depth in patients with periodontal disease. This is a specialized dental therapeutic with a narrow, well-defined indication.
$6MPart D
LOE ApproachingApproaching loss of exclusivity signals a contracting team; commercialization roles are likely being consolidated and brand defense strategies are critical.
Mechanism of Action
Mechanism of Action The mechanism of action of ARESTIN as an adjunct to scaling and root planing procedures for reduction of pocket depth in patients with adult periodontitis is unknown.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel
Started Nov 2014
47 enrolled
Acute PainBreast CarcinomaPeripheral Neuropathy
Career Relevance
Zero linked job postings suggest this is a mature, small-footprint product with a lean team and limited hiring. Working on ARESTIN offers deep expertise in niche dental therapeutics, regulatory defense, and LOE management but limited career growth opportunity or team expansion.
Brand Manager
Worked on ARESTIN at Fosun Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.